Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Serum vitamin D was significantly lower in the DN group (median, 16 ng/ml) when compared to the DM group (median, 21 ng/ml) [p < 0.001] and also when compared with control (median, 25 ng/ml) [p < 0.001], as seen in Fig. 1G.
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Case-control study.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
A case: control study was conducted involving three groups: healthy individuals (controls), diabetic patients without complications (DM), and diabetic nephropathy patients (DN).
Source: Abstract.
In addition to the case groups, 62 healthy control volunteers were enrolled from among hospital staff and community volunteers at Mustansiriyah University.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Serum brain-derived neurotrophic factor, micronutrient status, and inflammatory cytokines in type 2 diabetes with nephropathy: a case-control analysis
Case-control study · PeerJ · 2025
Original publication title
Serum brain-derived neurotrophic factor, micronutrient status, and inflammatory cytokines in type 2 diabetes with nephropathy: a case: control analysis
©2025 Waheed and Numan
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Brain-derived neurotrophic factor (BDNF) levels are lower in diabetic patients compared to healthy individuals, and may be further affected by nephropathy. This study aimed to evaluate serum BDNF levels in diabetic patients with nephropathy without complications and compare them to levels in healthy control subjects.
Source: BackgroundAbstract: What methods does the paper describe?
A case: control study was conducted involving three groups: healthy individuals (controls), diabetic patients without complications (DM), and diabetic nephropathy patients (DN). Serum BDNF levels were measured using the sandwich Enzyme-Linked Immunosorbent Assay (ELISA) technique, alongside serum levels of interleukin (IL)-12, IL-16, folic acid, vitamin B12, vitamin D3, total cholesterol, triglycerides, high density lipoprotein (HDL), hemoglobin A1c (HbA1c), urea, creatinine, total calcium, and zinc.
Source: MethodsAbstract: Results
Serum BDNF levels were significantly lower in the DN group compared to the DM and control groups (42.1, 34.1, and 27.23 ng/mL, respectively). In the DM group, BDNF showed a direct correlation with HbA1c and urea (r = 0.26 and r = 0.35, respectively), and an inverse correlation with fasting plasma glucose (FPG) (r = − 0.30). In the DN group, BDNF was directly correlated with FPG (r = 0.31) and serum creatinine (r = 0.27).
The area under the curve (AUC) for BDNF in distinguishing DN from controls was 0.938, and 0.738 for DN versus DM.
Source: ResultsAbstract: Conclusion
Serum BDNF levels are markedly reduced in type 2 diabetic patients with nephropathy and correlate with deficiencies in vitamins D, B12, folate, and zinc, as well as elevated IL-6 and IL-12. BDNF may serve as a biomarker for diabetic kidney disease, highlighting the importance of nutritional status, inflammation control, and neurotrophic support.
Source: ConclusionAuthors’ abstract
Background
Brain-derived neurotrophic factor (BDNF) levels are lower in diabetic patients compared to healthy individuals, and may be further affected by nephropathy. This study aimed to evaluate serum BDNF levels in diabetic patients with nephropathy without complications and compare them to levels in healthy control subjects.
Methods
A case: control study was conducted involving three groups: healthy individuals (controls), diabetic patients without complications (DM), and diabetic nephropathy patients (DN). Serum BDNF levels were measured using the sandwich Enzyme-Linked Immunosorbent Assay (ELISA) technique, alongside serum levels of interleukin (IL)-12, IL-16, folic acid, vitamin B12, vitamin D3, total cholesterol, triglycerides, high density lipoprotein (HDL), hemoglobin A1c (HbA1c), urea, creatinine, total calcium, and zinc.
Results
Serum BDNF levels were significantly lower in the DN group compared to the DM and control groups (42.1, 34.1, and 27.23 ng/mL, respectively). In the DM group, BDNF showed a direct correlation with HbA1c and urea (r = 0.26 and r = 0.35, respectively), and an inverse correlation with fasting plasma glucose (FPG) (r = − 0.30). In the DN group, BDNF was directly correlated with FPG (r = 0.31) and serum creatinine (r = 0.27).
The area under the curve (AUC) for BDNF in distinguishing DN from controls was 0.938, and 0.738 for DN versus DM.
Conclusion
Serum BDNF levels are markedly reduced in type 2 diabetic patients with nephropathy and correlate with deficiencies in vitamins D, B12, folate, and zinc, as well as elevated IL-6 and IL-12. BDNF may serve as a biomarker for diabetic kidney disease, highlighting the importance of nutritional status, inflammation control, and neurotrophic support.
Publication and source details
Original title: Serum brain-derived neurotrophic factor, micronutrient status, and inflammatory cytokines in type 2 diabetes with nephropathy: a case: control analysis
Huda Jaber Waheed; Nawfal A. Numan
PeerJ · 2025
©2025 Waheed and Numan2025Waheed and Numanhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.The authors received no funding for this work.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T00:57:51.367602+00:00
DOI: 10.7717/peerj.20086 · PMC12548638